O Brien Wealth Partners LLC Has $1.60 Million Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

O Brien Wealth Partners LLC cut its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 31.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 216,371 shares of the company's stock after selling 100,000 shares during the quarter. LifeStance Health Group accounts for 0.3% of O Brien Wealth Partners LLC's investment portfolio, making the stock its 22nd largest position. O Brien Wealth Partners LLC owned about 0.06% of LifeStance Health Group worth $1,595,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in LFST. The Manufacturers Life Insurance Company boosted its stake in LifeStance Health Group by 14.1% during the second quarter. The Manufacturers Life Insurance Company now owns 73,943 shares of the company's stock worth $363,000 after buying an additional 9,156 shares during the last quarter. Algert Global LLC acquired a new position in LifeStance Health Group during the 2nd quarter worth about $57,000. SG Americas Securities LLC lifted its stake in LifeStance Health Group by 406.4% during the 3rd quarter. SG Americas Securities LLC now owns 54,532 shares of the company's stock worth $382,000 after acquiring an additional 43,763 shares in the last quarter. Park Edge Advisors LLC purchased a new stake in LifeStance Health Group during the 3rd quarter worth about $73,000. Finally, Principal Financial Group Inc. raised its position in LifeStance Health Group by 6.1% in the 3rd quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company's stock valued at $28,817,000 after purchasing an additional 235,316 shares in the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at LifeStance Health Group

In related news, Director Robert Bessler sold 75,000 shares of the company's stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $7.54, for a total value of $565,500.00. Following the completion of the transaction, the director now directly owns 1,424,447 shares in the company, valued at approximately $10,740,330.38. This represents a 5.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 6.60% of the company's stock.

LifeStance Health Group Price Performance

LFST traded down $0.08 during trading on Wednesday, reaching $7.86. 364,770 shares of the stock were exchanged, compared to its average volume of 937,738. The business's 50 day moving average price is $7.66 and its two-hundred day moving average price is $7.04. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market capitalization of $3.01 billion, a price-to-earnings ratio of -30.23 and a beta of 1.28. LifeStance Health Group, Inc. has a 1 year low of $4.64 and a 1 year high of $9.20.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on LFST. The Goldman Sachs Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 target price on the stock in a research report on Monday, December 16th. Barclays lifted their target price on LifeStance Health Group from $6.00 to $7.00 and gave the company an "underweight" rating in a research note on Monday, November 11th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $8.70.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.